Chair of the Department of Cell, Developmental and Cancer Biology of the Knight Cancer Institute at the Oregon Health and ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

The immune system plays a key role in detecting and destroying cancer cells. Cancer immunotherapy works by programming immune ...

Researchers reveal how MAGE-4 and PTEN loss drive cancer growth, suppress immunity and point to new therapeutic strategies ...

SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...

Cancer cells alter the mitochondrial DNA (mtDNA), in turn causing mutations. Analysing this mechanism is a new breakthrough in the cancer research and treatment.

Researchers have identified the transfer of mitochondria with mutated DNA from cancer cells to immune cells as a key ...